QuidelOrtho Corp (QDEL) stock
QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3067% below fair value
$8.32−0.60 (-6.73%)
Close on Nov 20, 2026Market cap $570.55MP/E –Yield –
QuidelOrtho shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
QuidelOrtho's shares outstanding was 69M at Sep 27, 2026. For fiscal 2025 it was 68M, up 0.9% from the year before. The highest annual figure on record is 68M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 68M | +0.9% |
| FY2024 | Dec 29, 2024 | 67M | +0.6% |
| FY2023 | Dec 31, 2023 | 67M | +16.4% |
| FY2022 | Jan 1, 2023 | 57M | +33.8% |
| FY2021 | Jan 2, 2022 | 43M | -1.6% |
| FY2020 | Jan 3, 2021 | 44M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | 69M | +1.0% |
| Q2 FY2026 | Jun 28, 2026 | 68M | +0.9% |
| Q1 FY2026 | Mar 29, 2026 | 68M | +1.0% |
| Q4 FY2025 | Dec 28, 2025 | 68M | +0.9% |
| Q3 FY2025 | Sep 28, 2025 | 68M | +1.0% |
| Q2 FY2025 | Jun 29, 2025 | 68M | +0.9% |
| Q1 FY2025 | Mar 30, 2025 | 68M | +0.9% |
| Q4 FY2024 | Dec 29, 2024 | 68M | +1.0% |
| Q3 FY2024 | Sep 29, 2024 | 67M | +0.6% |
| Q2 FY2024 | Jun 30, 2024 | 67M | +0.4% |
| Q1 FY2024 | Mar 31, 2024 | 67M | -0.3% |
| Q4 FY2023 | Dec 31, 2023 | 67M | -0.3% |
| Q3 FY2023 | Oct 1, 2023 | 67M | -0.9% |
| Q2 FY2023 | Jul 2, 2023 | 67M | +26.3% |
| Q1 FY2023 | Apr 2, 2023 | 67M | +58.3% |
| Q4 FY2022 | Jan 1, 2023 | 67M | +51.9% |
| Q3 FY2022 | Oct 2, 2022 | 68M | +58.8% |
| Q2 FY2022 | Jul 3, 2022 | 53M | +24.8% |
| Q1 FY2022 | Apr 3, 2022 | 42M | – |
| Q4 FY2021 | Jan 2, 2022 | 44M | – |
| Q3 FY2021 | Oct 3, 2021 | 43M | – |
| Q2 FY2021 | Jul 4, 2021 | 42M | – |
See a number that looks wrong?